Cargando…

Integrins in multiple myeloma

Integrins have crucial roles in BM homing, survival, proliferation, or drug resistance of multiple myeloma (MM) cells. Especially, integrin α4β1 (VLA-4) and α4β7 has been reported to have important functions in MM cells, and therefore are potential therapeutic targets. We have recently shown that in...

Descripción completa

Detalles Bibliográficos
Autor principal: Hosen, Naoki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104491/
https://www.ncbi.nlm.nih.gov/pubmed/32256871
http://dx.doi.org/10.1186/s41232-020-00113-y
_version_ 1783512246222061568
author Hosen, Naoki
author_facet Hosen, Naoki
author_sort Hosen, Naoki
collection PubMed
description Integrins have crucial roles in BM homing, survival, proliferation, or drug resistance of multiple myeloma (MM) cells. Especially, integrin α4β1 (VLA-4) and α4β7 has been reported to have important functions in MM cells, and therefore are potential therapeutic targets. We have recently shown that integrin β7 constitutively adopts the active conformation specifically in MM cells, and found that chimeric antigen receptor (CAR) T cells targeting the activated conformation of integrin β7 is promising for MM. Although the mechanism for the constitutive activation is still being investigated, our results indicate that integrin conformation is different between MM and normal cells and suggest that it may be associated with the pathology of MM.
format Online
Article
Text
id pubmed-7104491
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-71044912020-04-01 Integrins in multiple myeloma Hosen, Naoki Inflamm Regen Review Integrins have crucial roles in BM homing, survival, proliferation, or drug resistance of multiple myeloma (MM) cells. Especially, integrin α4β1 (VLA-4) and α4β7 has been reported to have important functions in MM cells, and therefore are potential therapeutic targets. We have recently shown that integrin β7 constitutively adopts the active conformation specifically in MM cells, and found that chimeric antigen receptor (CAR) T cells targeting the activated conformation of integrin β7 is promising for MM. Although the mechanism for the constitutive activation is still being investigated, our results indicate that integrin conformation is different between MM and normal cells and suggest that it may be associated with the pathology of MM. BioMed Central 2020-03-30 /pmc/articles/PMC7104491/ /pubmed/32256871 http://dx.doi.org/10.1186/s41232-020-00113-y Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Review
Hosen, Naoki
Integrins in multiple myeloma
title Integrins in multiple myeloma
title_full Integrins in multiple myeloma
title_fullStr Integrins in multiple myeloma
title_full_unstemmed Integrins in multiple myeloma
title_short Integrins in multiple myeloma
title_sort integrins in multiple myeloma
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104491/
https://www.ncbi.nlm.nih.gov/pubmed/32256871
http://dx.doi.org/10.1186/s41232-020-00113-y
work_keys_str_mv AT hosennaoki integrinsinmultiplemyeloma